TCR antagonism is of particular interest for several reasons. Antagonist ligands may be involved in positive selection of T cells in the thymus (Hogquist et al., 1994) . Mutant viral proteins containing peptides that form antagonist ligands may allow viral escape from immune response, resulting in persistent viral infection (Klenerman et al., 1994; Bertoletti et al., 1994) . Synthetic peptides that form antagonist ligands may be used as drugs for specific therapy of autoimmune disease (Kuchroo et al., 1994; . Moreover, TCR antagonist ligands may act via a novel biochemical mechanism.
Three pieces of evidence strongly suggest that antagonist ligands are not classical competitive antagonists. First, some antagonist ligands are active at very low concentration (10 2 per APC), while the TCR is present at high concentration (10 4 per T cell) (Harding and Unanue, 1990; De Motz et al., 1990; Christianick et al., 1991; Klenerman et al., 1994; Bertoletti et al., 1994) . Second, the measured affinity of some antagonist ligands for the TCR in solution is very low (approximately one order of (Alam et al., 1996; Lyons et al., 1996) . Thus, it would (A) Probable alignment of these peptides when presented on the class II MHC protein I-E k . The recent x-ray crytstal structure of the be impossible for the low concentrations of antagonist Hb peptide bound to I-E k confirms that position 68 of Hb (isoleucine) ligands that are biologically active to block receptor occupies the P1 pocket with position 76 (lysine) in the P9 pocket occupation by antigenic ligand directly. Finally, antago- (Fremont et al., 1996) .
nist ligands themselves cause partial CD3 phosphory-(B) Name, sequence, and biological function of the altered peptides lation Madrenas et al., studied in this report.
1995). These observations suggest that antagonist ligands trigger a series of biochemical events that someagonist ligands to a lower level on the signaling hierarhow render T cells less responsive to antigen. chy. We conclude by discussing the implications of To investigate this mechanism in greater detail, we these findings for models of TCR antagonism. measured the ability of altered antigenic peptides presented on live APCs to trigger T cell acid release, calcium Results flux, and proliferation. Calcium flux and acid release are complimentary assays that both measure T cell activa-PL.17 T Cell Acid Release Response tion within minutes of receptor ligation (Weiss et al., to Altered Hemoglobin Ligands 1984a Ligands , 1984b Nag et al., 1992; McConnell et al., 1995) .
The PL.17 T cell clone is triggered by the peptide correAcid release (as measured on a microphysiometer) is a sponding to residues 64-76 of the hemoglobin-␤ d progeneral marker of cellular activity. Activation of most tein (the Hb peptide) bound to the MHC protein I-E k . The known signal transduction pathways can trigger inalignment of the Hb peptide in the MHC-binding grove creases in acid release . Such of I-E k , and the physiologic and biochemical responses increases may reflect either increased production of of the T cell clone PL.17 to altered Hb ligands, have acidic metabolites (e.g., lactate via glycolysis) or activabeen extensively evaluated in prior work (as summarized tion of membrane proton transport proteins (e.g., the in Figure 1 ; Evavold et al., 1992 Evavold et al., , 1994 Evavold et al., , 1995 ; Sloansodium-proton antiport) Wada Lancaster et al., 1993 , 1994 Fremont et al., 1996) . Thereet al., 1993) . Intracellular calcium is a crucial early secfore, this system was ideal for comparing acid release ond messenger, which is directly involved in T cell actito traditional measures of T cell activation. vation (Kaibuchi et al., 1985; Truneh et al., 1985; Desai We measured the acid release response of a mixture et al Weiss et al., 1984a Weiss et al., , 1984b . In contrast with of PL.17 T cells and APCs to previously studied single acid release, calcium flux can be recorded in single cells amino acid mutants of the Hb peptide ( Figure 1B ). Inas opposed to a bulk population of cells (Donnadieu et creased acid release is triggered by both Hb and partial al., 1992, 1994; Rö tnes and Bogen, 1994; Torigoe et al., agonist 74A at low peptide concentration ( Figure 2A ). 1995; Agrawal and Linderman, 1995) .
None of the antagonist ligands trigger acid release at In this report, we compare T cell acid release, calcium low concentration, but one (70M) markedly increased flux, and proliferation in response to different combinaacid release at high concentration ( Figure 2 ). This antagtions of agonist and antagonist ligands. We describe a onist has also been shown to cause transient spikes in hierarchy of T cell responses in which acid release and intracellular calcium in single cell calcium flux assays initial calcium flux are the easiest to trigger and prolifera-(J. Sloan-Lancaster and P. M. A., unpublished data). tion is the most difficult. The existence of such a hierarInactive ligand 72Q does not trigger acid release. Alchy indicates that early T cell signaling occurs in multiple though only one of the Hb antagonist ligands triggers (although not necessarily sequential) steps. The effect significant acid release at the peptide concentrations studied in this report, 70M and 70S both cause partial of antagonist ligands and anti-CD4 antibodies is to shift of altered Hb ligands to inhibit acid release triggered by Hb. We first measured response to 1 M Hb, added either simultaneous with, or up to 2 hr following, addition of 10 M 70S or 72Q. Antagonist ligand 70S, but not inactive ligand 72Q, caused a 20%-60% reduction in PL.17 acid release if added either simultaneous with or prior to Hb (three independent experiments, data not shown). These results raised the intriguing possibility that the antagonist ligand 70M might be able both to trigger, and to block, PL.17 acid release. Indeed, while 70M alone causes some acid release, addition of 70M followed by Hb results in reduced T cell acid release compared with addition of Hb alone ( Figure 2B ). The ability of antagonist ligands to block acid release is consistent with previous results demonstrating that antagonist ligands block other early T cell signals such as T cell phosphatidylinositol hydrolysis and calcium flux (Ruppert et al., 1993) .
5C.C7 T Cell Response to Altered Moth Cytochrome C Ligands Reveals More Stringent Requirements for Proliferation than for Acid Release or Calcium Flux
The 5C.C7 T cell line is derived from CD4 ϩ spleen cells from a 5C.C7 TCR transgenic mouse (Fink et al., 1986; Seder et al., 1992) . It is triggered by the peptide corresponding to residues 88-103 of the moth cytochrome c protein (the MCC peptide) bound to the MHC protein I-E k . The effect of mutation of the MCC peptide on IL-3 production by a partially transformed 5C.C7 T cell clone has been extensively evaluated (Reay et al., 1994) . In addition, the dissociation rate of altered MCC ligands from the 2B4 TCR (which is similar in sequence and ligand specificity to the 5C.C7 TCR) has been measured in solution and correlates with T cell biological response (Matsui et al., 1994; Lyons et al., 1996) . Based on these (Reay et al., 1994; P. A. Reay, unpub-M) was added during the interval indicated by the two shorter lished data), were included for comparison. The mutaarrows, and unbound peptide was washed away. Wild-type Hb (1 tions studied are in TCR contact residues (see Figure   M ) was added at the time indicated by the long arrow for the 1A). All of these peptides form stable complexes with remainder of the experiment. Squares received 70M peptide and I-E k (Reay et al., 1994 Only one of these altered ligands, 102S, a conservaalso measured in this experiment (data not shown). 73D alone retive single amino acid mutation (T→S) at a minor T cell sulted in only a very slight increase in acid release, but 73D was as contact, results in 5C.C7 T cell proliferation ( Figure 3A ).
effective as 70M in blocking response to Hb.
Moreover, 102S is the only altered MCC ligand to trigger marked acid release ( Figure 3B ). While the proliferation dose response to partial agonist 102S and wild-type CD3 chain phosphorylation and can induce long-last-MCC is very different, the acid release dose response ing T cell anergy ). Thereis almost identical (Figure 3 ). Moreover, no differences fore, all antagonist ligands may trigger some early T cell in acid release kinetics were noted between these two signaling, but this signaling does not always cause acid ligands ( Figure 3C ; for a detailed analysis of MCC rerelease.
sponse kinetics see Beeson et al., 1996) . Thus, it apTo investigate the mechanism by which antagonist ligands block T cell activation, we measured the ability pears that the requirements for triggering acid release . Similar acid release response to MCC and 102S was observed in greater than five independent experiments. Acid release response to 102G, 99R, 99E, 97I, and 97Q was <10% of response to 1 M MCC in all experiments using these peptides (all peptides were tested in at least two experiments at concentrations up to 10 M). are more easily fulfilled than those for triggering proliferonds, while others remained at elevated calcium concentrations for minutes. Undiluted 102S resulted in a ation. This is consistent with the ability of the Hb antagonist ligand M70 to trigger acid release but not prolifersimilar pattern of calcium response to 102S diluted 1:1,000 (data not shown), demonstrating that calcium ation.
We also measured the single cell calcium flux reflux, in contrast with acid release, depends only weakly on peptide dose. Comparing the acid release, calcium sponse of 5C.C7 T cells to APCs preloaded with various combinations of altered MCC ligands. In all experiments, flux, and proliferative responses to 102S reveals that transient calcium flux correlates with full acid release the biologically active peptides of interest were diluted into the inactive peptide 93E 99T 102A to yield a total ( Figure 3B ) but only minimal proliferation ( Figure 3A ). In contrast with the strong calcium response to agonist or peptide concentration of 25 M for APC loading. APCs were washed to remove all free peptide prior to the partial agonist at 1:1,000 dilution, even the undiluted antagonists 102G or 99R give no calcium flux in most addition of T cells. A 1:1,000 dilution of MCC or 102S (an MCC or 102S concentration of 25 nM) results in cells. However, a transient calcium flux was observed in >10% of 5C.C7 cells in response to 102G ( Figure 3D ). increased intracellular calcium in >90% of 5C.C7 T cells ( Figure 3D ). However, MCC and 102S trigger qualitatively different patterns of calcium flux, with 102S reAltered MCC Ligands Are More Efficient Antagonists of 5C.C7 Proliferation than of Acid sulting in some transient calcium flux responses (data not shown). These transient responses are character-
Release or Calcium Flux
To determine which of the altered MCC ligands are TCR ized by spikes to high intracellular calcium, followed by a return to basal levels. Some cells demonstrating antagonists, we measured the ability of 102S, 102G, 99R, and 99E to block 5C.C7 proliferation triggered by transient responses returned to basal levels within sec-a suboptimal concentration of MCC in a standard prepulse antagonism assay (De Magistris et al., 1992) . Not surprisingly, increasing the concentration of 102S enhances proliferation (data not shown). In contrast, 102G and 99R (but not 99E) are effective antagonists of T cell proliferation when added in 10-to 50-fold excess of MCC ( Figure 4A ).
To investigate how 99R and 102G block 5C.C7 proliferation, we measured their ability to block 5C.C7 calcium flux and acid release. As shown in circles in Figure  4B , addition of a 200-fold excess of 99R but not 99E prior to addition of a suboptimal amount of MCC inhibits 5C.C7 acid release. This parallels inhibition of PL.17 response to Hb by addition of antagonist prior to agonist. To determine whether the sequence of addition of agonist and antagonist is important, we also added 99R and 99E to cells that had already been triggered by MCC. As shown in squares in Figure 4B , addition of an antagonist peptide rapidly decreases 5C.C7 acid release. Thus, acid release depends on the relative amounts of agonist and antagonist ligands present at any given time, regardless of the order of addition. Another interesting aspect to this experiment is the relatively small decrease caused by the 200-fold excess of antagonist (10 M). This excess of antagonist is sufficient to block most 5C.C7 cell proliferation.
The effect of antagonists on calcium flux is consistent with their effects on proliferation and acid release. As shown in Figure 4C , the presence of even a 1,000-fold excess of 102G or 99R relative to MCC has only a slight effect on the percentage of cells giving a positive calcium flux response. However, antagonist ligands are capable of converting agonist-type calcium flux (full signals in all cells) to partial agonist type calcium flux (transient flux in some cells) (data not shown). To study further the effect of antagonist on calcium flux, we reduced the agonist ligand concentration 10-fold, while keeping the antagonist ligand concentration the same. In this case, both 102G and 99R greatly reduce the frequency of a positive calcium flux responses ( Figure 4C ). However, even this large excess of antagonist (10,000-fold) does not eliminate all calcium flux. Thus, it appears that blocking calcium flux, like blocking acid release, is more difficult than blocking proliferation. This result is in contrast with previous work demonstrating that the ability to block calcium flux and proliferation are strongly correlated (Ruppert et al., 1993) . A likely explanation for this discrepancy is that Ruppert et al. measure bulk, rather than single cell, calcium flux. et al. , 1985) . We were interested in examining the effect of the anti-CD4 antibody GK1.5 on T cell response to different altered ligands. We first measured the ability of anti-CD4 to block T cell proliferation. Figure 5 shows the effect of varying concentrations of anti-CD4 on 5C.C7 proliferation. Plotted is dose response to wildtype MCC ( Figure 5A ) or partial agonist 102S ( Figure 5B ) in the presence of a fixed concentration of anti-CD4. A low concentration of anti-CD4 (100 ng/mL) only slightly inhibits proliferation in response to MCC but completely eliminates the response to 102S. A 10-fold greater concentration of anti-CD4 blocks most but not all proliferation caused by MCC. GK1.5 Fab fragments produce similar results (data not shown), demonstrating that the effect of GK1.5 does not require cross-linking of CD4. The ability of wild-type MCC but not partial agonist 102S to trigger proliferation in the presence of 100 ng/mL anti-CD4 allows the measurement of 102S antagonist function. As shown in Figure 5C , in the presence of anti-CD4 and MCC, increasing concentrations of 102S block 5C.C7 proliferation. Because the APCs are prepulsed with MCC, this blockade cannot be due to competition for MHC binding and must result from a TCR specific effect. Thus, anti-CD4 converts a partial agonist into a TCR antagonist. A similar result has been previously reported for CD8 ϩ T cells (Jameson et al., 1994) . To investigate the mechanism by which anti-CD4 blocks proliferation, we measured 5C.C7 acid release and calcium flux in the presence of anti-CD4. In control experiments, we found that in the absence of peptide, anti-CD4 does not trigger acid release or calcium flux (data not shown). Figure 6A shows that the acid release response to 102S is not inhibited by a concentration of anti-CD4 (100 ng/mL), which completely blocks proliferation response. Figure 6B summarizes the effect of anti-CD4 on calcium flux response to MCC and 102S. While 1 g/mL anti-CD4 does not completely block calcium flux response to MCC or 102S, it tends to convert calcium flux from an agonist to a partial agonist pattern (data not shown).
Discussion

Defining a Hierarchy of Early T Cell Responses
Binding of the TCR and CD4 coreceptor protein to their ligand, a complex of an antigenic peptide and a class II MHC protein, activates helper T cells. Binding of an altered ligand may cause partial T cell activation, block T cell response to agonist ligand, or both. To investigate the molecular mechanism of this differential T cell re- ing. Partial phosphorylation is one event triggered by taken from Evavold et al. (1994) . In the case of phosphorylation, a single plus indicates predominant production of the p21 isoform, while two plus signs indicate significant production of the p23 antagonist ligands that probably does not significantly isoform.
increase acid release. production (Evavold and Allen, 1991) . We found that ligands like 102S, which trigger acid release but not proliferation, result in increased intracellular calcium in As a unit, and in combination with previous biochemical studies ; Madrenas et most T cells. However, such ligands result in transient, rather than sustained, increases in intracellular calcium al., 1995), these results suggest a hierarchy of measures of T cell activation (Figure 7) . At the bottom of the hierarin many cases. Transient calcium fluxes triggered by suboptimal TCR activation have been previously shown chy is initial CD3 chain phosphorylation, as it is triggered by ligands that failed to trigger any detectable to result in deficient IL-2 production (Goldsmith and Weiss, 1988) .
response in this report (e.g., 70S, Figure 2) . Just above phosphorylation are initial calcium flux and acid resignaling, it is not surprising that they tend to induce a shift from a Th1 to a Th2 type cytokine profile (Stumbles lease, as these responses are triggered by a large number of different stimuli, many of which fail to yield T cell and Mason, 1995) . The ability of both antagonist ligands and anti-CD4 proliferation. Of these two assays, calcium flux is slightly more sensitive (e.g., 102G alone results in a very small to reduce the fraction of complete T cell signals suggests that both act to shift T cell response to a lower but detectable calcium flux response but no detectable increase in acid release). This is probably because a position on the hierarchy of signaling steps (Figure 7 ). Based on this idea, we predict that it will be much easier single cell assay (calcium flux) is more effective than an assay of bulk cellular response (acid release) for to block proliferation response to partial agonist than to wild-type agonist, as partial agonist starts at a lower detecting a small response in a small fraction of cells. Higher up are various types of sustained increases in position on the signaling hierarchy. Indeed, we have found that an equimolar amount of 102G is sufficient to intracellular calcium, which can be subdivided based on the precise temporal pattern of T cell response (C. W.
block proliferation response to 102S (C. B., unpublished data). Thus, one possible explanation for the ability of et al., unpublished data). At the top of the hierarchy is T cell proliferation, which requires nearly ideal activation some antagonists to block T cell response when the agonist is in molar excess (Bertoletti et al., 1994 ; Klenerconditions. These conditions include the appropriate APC and microenvironment (reviewed by Janeway and man et al., 1994) is that the agonists used in these reports might be suboptimal. Bottomly, 1994), as well as the appropriate ligand. In contrast with proliferation, and in accordance with their lower location on the hierarchy, acid release and calcium Continuous Spectrum of T Cell Responses Supports a Kinetic Discrimination Model flux are relatively insensitive to APC type (Beeson et al., 1996; Jenkins et al., 1987) .
of T Cell Activation and Antagonism
Two main hypotheses have been proposed to account An important question raised by this hierarchy is whether the different responses are causally related for the difference in T cell response to agonist versus antagonist ligands. These competing models can be (e.g., phosphorylation causes calcium flux, which causes acid release and proliferation). Acid release but labeled as a conformation model and a kinetic discrimination model. The conformation model claims that annot calcium flux depends strongly on peptide dose. Moreover, acid release increases steadily for at least tagonist ligand binding results in a conformation of the TCR, which sends an incomplete or negative signal that the first 30 min of T cell stimulation, while intracellular calcium frequently peaks rapidly and then declines can block response to antigen. Included in this idea are models where the shape of the antagonist ligand results within minutes of T cell activation. These disparities suggest that acid release and calcium flux, despite occuring in failure to recruit CD4 (Yoon et al., 1994) or failure to achieve appropriate TCR dimerization (Sette et al., during a similar time frame and in response to similar stimuli, are independent responses triggered by differ-1994). In its simplest form, this model predicts a dichotomy between ligands that induce the correct conformaent signaling pathways. Thus, at least some of the responses on the signaling hierarchy appear not to be tion (agonists) and ligands that induce the other conformation (antagonists). In the kinetic discrimination model, causally related and rather to be complementary measures of TCR signaling. a variant of kinetic proofreading (McKeithan, 1995) , both agonist and antagonist ligands bind the TCR in an identical manner. The only difference is that agonist ligands Antagonist Ligands and Anti-CD4 Antibodies bind to the TCR for a longer duration than antagonist Shift Agonist Ligands to a Lower Level ligands. In such a model, brief TCR occupation by an on the Signaling Hierarchy antagonist ligand triggers incomplete signaling that can The ability of antagonist ligands to block early T cell block response to agonist (Rabinowitz et al., 1996) . This signaling (Ruppert et al., 1993) , but not always all cytomodel is supported by direct measurements of the diskine production (Racioppi et al., 1993) raises the followsociation rate of mutant MCC ligands for the 2B4 TCR ing dilemma: if early signaling is blocked, how can some (Matsui et al., 1994; Lyons et al., 1996) and by evidence cytokine production persist? The analysis of early T cell that ligands causing partial T cell activation tend to have signaling in this report (as summarized in Figure 7 ) prolower TCR affinities and faster dissociation rates than vides a simple solution to this dilemma. We find that ligands triggering full T cell activation (Al-Ramadi et al., antagonist ligands have a dual affect on T cell signaling 1995; Alam et al., 1996; Margulies, 1996) . It predicts that when measured at the level of single cell calcium flux. the continuous range of dissociation rates of ligands This effect is to reduce both the fraction of cells refrom the TCR will result in a continuous spectrum of T sponding to agonist, and the fraction of these responses cell responses. The data in this report (as summarized that are complete. Because a mixture of complete and in Figure 7 ) provide evidence for a continuous spectrum incomplete signals is probably sufficient for production of T cell responses, suggesting that the kinetic discrimiof some but not all cytokines (Evavold and Allen, 1991;  nation model is a likely possibility. Racioppi et al., 1993; Windhagen et al., 1995) , these
The coreceptor CD4 contributes both to the stability of results explain both the strong correlation between ligand-TCR interaction and (via Lck) to the intracellular blockade of early signaling and blockade of proliferaevents required for complete T cell signaling. Therefore, tion, and the ability to block selectively the production the kinetic discrimination model (as well as some conforof a subset of cytokines. As anti-CD4 antibodies have mation models in which CD4 recruitment is crucial) predicts that reduction in CD4 expression will convert some a similar effect to antagonist ligands on early T cell agarose (Molecular Devices, Sunnyvale, California) at 37ЊC. The agapartial agonist ligands causing T cell proliferation into rose cell mixture (10 L) was immediately spotted onto the memligands blocking proliferation. We tested this hypothesis brane of a Cytosensor cell capsule (Molecular Devices, Sunnyvale, using anti-CD4 monoclonal antibodies to approximate California). After 10 min, the cell capsule was assembled and loaded a reduction in CD4 expression. As predicted, in the microphysiometer chamber maintained at 37ЊC. The chamber converted a partial agonist ligand into an antagonist was perfused (50 L/min) with low buffer RPMI 1640 medium (Molecular Devices, Sunnyvale, California) containing 1 mM sodium phosligand. Recent results have also shown that increasing phate, 1 mg/mL endotoxin-free bovine serum albumin (Calbiochem, CD4 expression can convert an antagonist into an agoSan Diego, California), and no bicarbonate (pH 7.4). The rate of acid nist, and, most interestingly, an inactive ligand into an release was determined with 20 s potentiometric rate measurements antagonist (Vidal et al., 1996) . This final result is consisafter a 58 s pump cycle and 10 s delay (total cycle time, 90 s). tent with a kinetic discrimination model but not conforBaseline acid release rates were between 60-100 V s Ϫ1 .
mation models in which CD4 recruitment is crucial. An unresolved question raised by the kinetic discrimi- by agonist ( Figure 4B ) further supports this notion. These incomplete receptor activation presents a challenge for future investigation of TCR antagonism.
Cell Proliferation
Proliferation of 5C.C7 T cells was measured as the uptake of Experimental Procedures ]thymidine at 48 Peptides were synthesized with standard FMOC chemistry, purified hr and cell DNA was harvested at 64 hr. Background radioactivity by reverse phase high pressure liquid chromatography, and characwas <1,000 cpm. terized either by mass spectroscopy or amino acid content. Anti-CD4 antibody GK1.5 (anti-L3T4) was purchased from Becton-DickAcknowledgments inson (Bedford, Massachusetts).
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Cell Lines
Boniface for the altered MCC peptides and advice, and M. Liang The MCC-specific 5C.C7 T cells were derived from the 5C.C7 ␣␤ for many valuable discussions. This work was supported by the TCR transgenic mouse (Fink et al., 1986; Seder et al., 1992) . Spleen Medical Scientist Training Program (J. D. R.), the Cancer Research cells were primed with 10 M MCC and expanded for 8 days in IL-2 Institute (C. B.), the European Molecular Biology Organization containing medium. The T cells (1 ϫ 10 6 cells/mL) were restimulated (C. W.), and grants from the National Institutes of Health. Peptides with irradiated (3,000 rads) B10.BR spleen cells and 10 M MCC.
were characterized at the Mass Spectroscopy Facilities at the UniAfter 10 days of culture and expansion in the presence of IL-2, CD4 ϩ versity of California, San Francisco. cells were sorted by flow cytometry and restimulated in 10 day intervals. The Hb-specific PL.17 T cell clone was grown as previously Received May 23, 1996; revised July 18, 1996. described (Lorenz and Allen, 1989; Evavold et al., 1992 Evavold et al., , 1994 ). CH27 cells are an H-2 k B cell lymphoma that expresses the I-E k /I-A k MHC References class II molecules, ICAM-1, and B7 costimulatory molecules. Chinese hampster ovary (CHO) cells transfected with I-E k were grown Abraham, N., Miceli, M.C., Parnes, J.R., and Veillette, A. (1991) . as previously described (Wettstein et al., 1991) .
Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56 lck . Nature 350, 62-66. Microphysiometry Agrawal, N., and Linderman, J.J. (1995) . Calcium response of helper Acid release was measured as described previously (McConnell et T lymphocytes to antigen-presenting cells in a single-cell assay. al., 1995). In brief, T cells rested from stimulation (9-13 days) were Biophys. J. 69, 1178-1190. combined with APCs that had been cultured overnight in RPMI 1640
Alam, S.M., Travers, P.J., Wung, J.L., Nasholds, W., Redpath, S., medium containing 2.5% fetal calf serum. Cells were mixed at a Jameson, S.C., and Gascoigne, N.R.J. (1996) . T-cell receptor affinity ratio of twenty T cells to one APC and collected by centrifugation.
and thymocyte positive selection. Nature 381, 616-620. The cell pellet (3-6 ϫ 10 6 cells) was resuspended in 105 L medium, which was mixed with 35 L of melted low temperature-melting Al-Ramadi, B.K., Jelonek, M.T., Boyd, L.F., Margulies, D.H., and
